Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized, Plasma-Controlled, Phase IIIb Study

Sarode Ravi; Milling Truman J. Jr.; Refaai Majed A.; Mangione Antoinette; Schneider Astrid; Durn Billie L.; Goldstein Joshua N.

首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized, Plasma-Controlled, Phase IIIb Study

【24h】

Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized, Plasma-Controlled, Phase IIIb Study

机译：4因子凝血酶原复合物浓缩物对主要出血患者的维生素K拮抗剂治疗的有效性和安全性，随机对照血浆IIIb期研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background-

机译：背景-

著录项

来源
《Circulation: An Official Journal of the American Heart Association》 |2013年第11期|共10页
作者
Sarode Ravi; Milling Truman J. Jr.; Refaai Majed A.; Mangione Antoinette; Schneider Astrid; Durn Billie L.; Goldstein Joshua N.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
vitamin K antagonist; hemorrhage; prothrombin complex concentrates; plasma; anticoagulants;

机译：维生素K拮抗剂;出血;凝血酶原复合物浓缩物;血浆;抗凝剂;

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized, Plasma-Controlled, Phase IIIb Study [J] . Sarode Ravi, Milling Truman J. Jr., Refaai Majed A., Circulation: An Official Journal of the American Heart Association . 2013,第11期

机译：4因子凝血酶原复合物浓缩物对主要出血患者的维生素K拮抗剂治疗的有效性和安全性，随机对照血浆IIIb期研究
2. Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized, Plasma-Controlled, Phase IIIb Study [J] . Sarode Ravi, Milling Truman J. Jr., Refaai Majed A., Circulation: An Official Journal of the American Heart Association . 2013,第11期

机译：4因子凝血酶原复合物浓缩物对主要出血患者的维生素K拮抗剂治疗的有效性和安全性，随机对照血浆IIIb期研究
3. Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study [J] . Shigeki Kushimoto, Toshio Fukuoka, Akio Kimura, International journal of hematology . 2017,第6期

机译：4因素凝血酶浓缩物的疗效和安全性在日本患者中快速维生素K拮抗剂逆转的效果和安全性，或者需要紧急外科手术或侵入手术：前瞻性，开放标签，单臂第3B研究
4. SAFETY AND EFFICACY OF HOLMIUM:YAG LASER LITHOTRIPSY IN PATIENTS WITH BLEEDING DIATHESES [C] . James D. Watterson, Andrew R. Girvan, Anthony J. Cook, Conference on lasers in surgery: Advanced characterization, therapeutics, and systems . 2003

机译：钬的安全性和有效性：患有出血性乳糖患者的YAG激光碎石术
5. The Bleeding Risk of Non-Vitamin K Antagonist Oral Anticoagulants in Cirrhotic Patients: A Systematic Review and Meta-Analysis [D] . Go, Rafael Francisco C. 2020

机译：肝硬化患者中非维生素K拮抗剂口腔抗凝剂的出血风险：系统审查和荟萃分析
6. Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized Plasma-Controlled Phase IIIb Study [O] . Ravi Sarode, Truman J. Milling Jr, Majed A. Refaai, -1

机译：4-因子凝血酶原复合物浓缩物对主要出血患者的维生素K拮抗剂的有效性和安全性随机对照血浆IIIb期研究
7. Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding [O] . Ravi Sarode, Truman J. Milling, Majed A. Refaai, 2013

机译：一种4因素凝血酶浓缩物在患有主要出血的维生素K拮抗剂患者中的疗效和安全性

Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized, Plasma-Controlled, Phase IIIb Study

摘要

著录项

相似文献

相关主题

期刊订阅